968 related articles for article (PubMed ID: 32693757)
1. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
Musyuni P; Aggarwal G; Nagpal M; Goyal RK
Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
[TBL] [Abstract][Full Text] [Related]
2. Insights into Novel Coronavirus Disease 2019 (COVID-19): Current Understanding, Research, and Therapeutic Updates.
Sushma DS; Jaiswal V; Kumar A; Asha S; Pal T
Recent Pat Biotechnol; 2022; 16(1):35-63. PubMed ID: 34353275
[TBL] [Abstract][Full Text] [Related]
3. Technological Innovations in Disease Management: Text Mining US Patent Data From 1995 to 2017.
Huang M; Zolnoori M; Balls-Berry JE; Brockman TA; Patten CA; Yao L
J Med Internet Res; 2019 Apr; 21(4):e13316. PubMed ID: 31038462
[TBL] [Abstract][Full Text] [Related]
4. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
[TBL] [Abstract][Full Text] [Related]
5. COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
Khan T; Agnihotri K; Tripathi A; Mukherjee S; Agnihotri N; Gupta G
Altern Ther Health Med; 2020 Aug; 26(S2):56-64. PubMed ID: 32412918
[TBL] [Abstract][Full Text] [Related]
6. Patents Related to Pathogenic Human Coronaviruses.
Dos Santos M; Ferreira AVF; da Silva JO; Nogueira LM; Machado JM; Francisco MFC; da Paz MC; Giunchetti RC; Galdino AS
Recent Pat Biotechnol; 2021; 15(1):12-24. PubMed ID: 33504319
[TBL] [Abstract][Full Text] [Related]
7. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
Siri JGS; Fernando CAN; De Silva SNT
Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
[TBL] [Abstract][Full Text] [Related]
9. Information Disclosed in Patent Documents being the Source to Address Emergencies: A Strategy to Achieve Technological Developments Addressing COVID-19.
Martins TD; Cordeiro DS
Recent Pat Biotechnol; 2021 Oct; 15(2):148-163. PubMed ID: 33797389
[TBL] [Abstract][Full Text] [Related]
10. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.
Schwartz DA; Graham AL
Viruses; 2020 Feb; 12(2):. PubMed ID: 32050635
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
12. Global landscape of patents related to human coronaviruses.
Liu K; Gu Z; Islam MS; Scherngell T; Kong X; Zhao J; Chen X; Hu Y
Int J Biol Sci; 2021; 17(6):1588-1599. PubMed ID: 33907523
[TBL] [Abstract][Full Text] [Related]
13. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
[TBL] [Abstract][Full Text] [Related]
14. An update on novel COVID-19 pandemic: a battle between humans and virus.
Prajapati S; Sharma M; Kumar A; Gupta P; Narasimha Kumar GV
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5819-5829. PubMed ID: 32495921
[TBL] [Abstract][Full Text] [Related]
15. Recent Patents and Advances on Nanotechnologies against Coronavirus.
Abedini-Nassab R; Mahdaviyan N
Recent Pat Nanotechnol; 2021; 15(4):322-330. PubMed ID: 33172382
[TBL] [Abstract][Full Text] [Related]
16. Intellectual Property Rights and Vaccines.
Gilbert P; Fawcett R; Coles J; Hillson W
Methods Mol Biol; 2022; 2412():505-518. PubMed ID: 34918265
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: The outbreak caused by a new coronavirus.
Sifuentes-RodrÃguez E; Palacios-Reyes D
Bol Med Hosp Infant Mex; 2020; 77(2):47-53. PubMed ID: 32226003
[TBL] [Abstract][Full Text] [Related]
18. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)].
Yang KL; Gao Y; Yang FW; Liu M; Shi SZ; Chen YM; Zhang JH; Tian JH
Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):3001-3006. PubMed ID: 32726004
[TBL] [Abstract][Full Text] [Related]
20. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
